Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-96,page-paged-96,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim
    20 March 2019
    www.motifbio.com
  • Probiodrug and Alzheimer’s Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Program for PQ912
    20 March 2019
    www.probiodrug.de
  • MorphoSys and I-Mab Biopharma Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma
    19 March 2019
    www.morphosys.com
  • AiCuris plant sein weiteres Wachstum in Wuppertal
    19 March 2019
    www.aicuris.com
  • Medigene AG: Medigene presented paths to potential neoantigen-based TCR-therapies
    19 March 2019
    www.medigene.com
  • Expedeon Announces Supervisory Board Changes
    14 March 2019
    www.expedeon.com
  • Molecular Health’s MH Guide shortlisted for the German Digital Health Award 2019
    14 March 2019
    www.molecularhealth.com
  • Abivax 2018 Financial Results and Operations Update
    14 March 2019
    www.abivax.com
  • MorphoSys Presents Results for Fiscal Year 2018
    13 March 2019
    www.morphosys.com
  • Sterna biologicals holds Scientific Advisory Board meetings to advance phase IIb clinical development program of SB010 in asthma
    12 March 2019
    www.sterna-biologicals.com